PCM
BDSI

Penserra Capital Management’s BioDelivery Sciences International, Inc. BDSI Stock Holding History

Penserra Capital Management’s Portfolio BDSI Stock Details BDSI Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q4 		– Sell
-2,255
Closed -$8K – 1669
2021
Q3 		$8K Buy
2,255
+10
+0.4% +$38 ﹤0.01% 1388
2021
Q2 		$8K Sell
2,245
-65
-3% -$229 ﹤0.01% 1291
2021
Q1 		$9K Sell
2,310
-10
-0.4% -$41 ﹤0.01% 1054
2020
Q4 		$9K Buy
2,320
+1,462
+170% +$5.63K ﹤0.01% 945
2020
Q3 		$3K Buy
+858
New +$3.65K ﹤0.01% 899

Other funds holding BDSI

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
SFM
Systematic Financial Management Teaneck, New Jersey $4.36B AUM 40.56% 1-Year Est. Return
LSV Asset Management
LSV Asset Management Chicago, Illinois $46.4B AUM 27.74% 1-Year Est. Return
RA
Royce & Associates New York $10.1B AUM 42.88% 1-Year Est. Return
WA
Wasatch Advisors Salt Lake City, Utah $15.3B AUM 25.06% 1-Year Est. Return
MF
Magnetar Financial Evanston, Illinois $9.84B AUM 190.64% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
RCMNY
Rubric Capital Management (New York) New York $9.44B AUM 68.42% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Penserra Capital Management's BDSI Position: Q4 2021 in Review

Penserra Capital Management sold out of BioDelivery Sciences International, Inc. (BDSI) in Q4 2021, closing a stake of 2,255 shares — an estimated $8K sold.

Penserra Capital Management first reported a position in BDSI in Q3 2020 and held it in 5 quarters. The position peaked at $9K in Q1 2021. 156 funds tracked by Wall St. Rank hold BDSI as of Q4 2021.

  • Penserra Capital Management reported no remaining BioDelivery Sciences International, Inc. position as of Q4 2021 after selling out during the quarter.
  • Penserra Capital Management sold 2,255 BioDelivery Sciences International, Inc. shares in Q4 2021, an estimated $8K.
  • Penserra Capital Management first reported a position in BioDelivery Sciences International, Inc. in Q3 2020 and held it in 5 quarters.
  • Penserra Capital Management's BioDelivery Sciences International, Inc. position peaked at $9K in Q1 2021.
  • 156 funds tracked by Wall St. Rank held BioDelivery Sciences International, Inc. as of Q4 2021.

Based on Penserra Capital Management's 13F filing for Q4 2021, filed 15 Feb 2022.